Stockreport

JNJ Seeks FDA Approval for Oral Psoriasis Drug Icotrokinra [Yahoo! Finance]

Arvinas, Inc.  (ARVN) 
Last arvinas, inc. earnings: 11/4 05:00 pm Check Earnings Report
PDF peptide, icotrokinra, for treating moderate-to-severe plaque psoriasis (PsO) in adults and pediatric patients aged 12 years and above. The NDA was based on data from f [Read more]